BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

330 related articles for article (PubMed ID: 31935836)

  • 1. Mesenchymal Stromal Cells from Fetal and Maternal Placenta Possess Key Similarities and Differences: Potential Implications for Their Applications in Regenerative Medicine.
    Papait A; Vertua E; Magatti M; Ceccariglia S; De Munari S; Silini AR; Sheleg M; Ofir R; Parolini O
    Cells; 2020 Jan; 9(1):. PubMed ID: 31935836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Placenta-Derived Adherent Stromal Cell Therapy for Hematopoietic Disorders: A Case Study of PLX-R18.
    Sher N; Ofir R
    Cell Transplant; 2018 Jan; 27(1):140-150. PubMed ID: 29562777
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of Desmoglein 2, Desmocollin 3 and Plakophilin 2 in Placenta and Bone Marrow-Derived Mesenchymal Stromal Cells.
    Hart ML; Rusch E; Kaupp M; Nieselt K; Aicher WK
    Stem Cell Rev Rep; 2017 Apr; 13(2):258-266. PubMed ID: 28154962
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Chorion Mesenchymal Stem Cells Show Superior Differentiation, Immunosuppressive, and Angiogenic Potentials in Comparison With Haploidentical Maternal Placental Cells.
    González PL; Carvajal C; Cuenca J; Alcayaga-Miranda F; Figueroa FE; Bartolucci J; Salazar-Aravena L; Khoury M
    Stem Cells Transl Med; 2015 Oct; 4(10):1109-21. PubMed ID: 26273064
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Avoidance of Maternal Cell Contamination and Overgrowth in Isolating Fetal Chorionic Villi Mesenchymal Stem Cells from Human Term Placenta.
    Sardesai VS; Shafiee A; Fisk NM; Pelekanos RA
    Stem Cells Transl Med; 2017 Apr; 6(4):1070-1084. PubMed ID: 28205414
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The role of placental-derived adherent stromal cell (PLX-PAD) in the treatment of critical limb ischemia.
    Prather WR; Toren A; Meiron M; Ofir R; Tschope C; Horwitz EM
    Cytotherapy; 2009; 11(4):427-34. PubMed ID: 19526389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunomodulatory placental-expanded, mesenchymal stromal cells improve muscle function following hip arthroplasty.
    Winkler T; Perka C; von Roth P; Agres AN; Plage H; Preininger B; Pumberger M; Geissler S; Hagai EL; Ofir R; Pinzur L; Eyal E; Stoltenburg-Didinger G; Meisel C; Consentius C; Streitz M; Reinke P; Duda GN; Volk HD
    J Cachexia Sarcopenia Muscle; 2018 Oct; 9(5):880-897. PubMed ID: 30230266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Isolation of mesenchymal stem cells of fetal or maternal origin from human placenta.
    In 't Anker PS; Scherjon SA; Kleijburg-van der Keur C; de Groot-Swings GM; Claas FH; Fibbe WE; Kanhai HH
    Stem Cells; 2004; 22(7):1338-45. PubMed ID: 15579651
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of culture media on the derivation and phenotype of fetal-derived placental mesenchymal stem/stromal cells across gestation.
    Boss AL; Brooks AES; Chamley LW; James JL
    Placenta; 2020 Nov; 101():66-74. PubMed ID: 32932101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mesenchymal stromal cell characteristics vary depending on their origin.
    Wegmeyer H; Bröske AM; Leddin M; Kuentzer K; Nisslbeck AK; Hupfeld J; Wiechmann K; Kuhlen J; von Schwerin C; Stein C; Knothe S; Funk J; Huss R; Neubauer M
    Stem Cells Dev; 2013 Oct; 22(19):2606-18. PubMed ID: 23676112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparative phenotypic transcriptional characterization of human full-term placenta-derived mesenchymal stromal cells compared to bone marrow-derived mesenchymal stromal cells after differentiation in myogenic medium.
    Hart ML; Kaupp M; Brun J; Aicher WK
    Placenta; 2017 Jan; 49():64-67. PubMed ID: 28012456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. B Lymphocytes as Targets of the Immunomodulatory Properties of Human Amniotic Mesenchymal Stromal Cells.
    Magatti M; Masserdotti A; Bonassi Signoroni P; Vertua E; Stefani FR; Silini AR; Parolini O
    Front Immunol; 2020; 11():1156. PubMed ID: 32582218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Isolation of mesenchymal stem cells from human placenta: comparison with human bone marrow mesenchymal stem cells.
    Miao Z; Jin J; Chen L; Zhu J; Huang W; Zhao J; Qian H; Zhang X
    Cell Biol Int; 2006 Sep; 30(9):681-7. PubMed ID: 16870478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stem cells isolated from the human stromal limbus possess immunosuppressant properties.
    Garfias Y; Nieves-Hernandez J; Garcia-Mejia M; Estrada-Reyes C; Jimenez-Martinez MC
    Mol Vis; 2012; 18():2087-95. PubMed ID: 22876135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of the Biological Characteristics of Mesenchymal Stem Cells Derived from the Human Placenta and Umbilical Cord.
    Wu M; Zhang R; Zou Q; Chen Y; Zhou M; Li X; Ran R; Chen Q
    Sci Rep; 2018 Mar; 8(1):5014. PubMed ID: 29568084
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of feto-maternal organ derived stem cells in facets of immunophenotype, proliferation and differentiation.
    Indumathi S; Harikrishnan R; Mishra R; Rajkumar JS; Padmapriya V; Lissa RP; Dhanasekaran M
    Tissue Cell; 2013 Dec; 45(6):434-42. PubMed ID: 24008115
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Allogenic Use of Human Placenta-Derived Stromal Cells as a Highly Active Subtype of Mesenchymal Stromal Cells for Cell-Based Therapies.
    Gorodetsky R; Aicher WK
    Int J Mol Sci; 2021 May; 22(10):. PubMed ID: 34069909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Establishment and characterization of fetal and maternal mesenchymal stem/stromal cell lines from the human term placenta.
    Qin SQ; Kusuma GD; Al-Sowayan B; Pace RA; Isenmann S; Pertile MD; Gronthos S; Abumaree MH; Brennecke SP; Kalionis B
    Placenta; 2016 Mar; 39():134-46. PubMed ID: 26992686
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of immune modulatory properties of human multipotent mesenchymal stromal cells derived from bone marrow and placenta.
    Sarıkaya A; Aydın G; Özyüncü Ö; Şahin E; Uçkan-Çetinkaya D; Aerts-Kaya F
    Biotech Histochem; 2022 Feb; 97(2):79-89. PubMed ID: 33641543
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mesenchymal Stromal Cells Prevent Allostimulation In Vivo and Control Checkpoints of Th1 Priming: Migration of Human DC to Lymph Nodes and NK Cell Activation.
    Consentius C; Akyüz L; Schmidt-Lucke JA; Tschöpe C; Pinzur L; Ofir R; Reinke P; Volk HD; Juelke K
    Stem Cells; 2015 Oct; 33(10):3087-99. PubMed ID: 26184374
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.